Related references
Note: Only part of the references are listed.Innate Cytokine Induced Early Release of IFN gamma and CC Chemokines from Hypoxic Human NK Cells Is Independent of Glucose
Sonia Y. Velasquez et al.
CELLS (2020)
Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells
Jolie R. Schafer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Simona Sivori et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Immunometabolism and natural killer cell responses
Katie L. O'Brien et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions
Niken M. Mahaweni et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism
Vanessa Zaiatz-Bittencourt et al.
JOURNAL OF IMMUNOLOGY (2018)
A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity
Xiao Zhou et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise
Vijay Ramakrishnan et al.
LEUKEMIA & LYMPHOMA (2018)
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
Aurelia Lamanuzzi et al.
Oncotarget (2018)
Acquired natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
Jodi Chiu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
Fangjie Wang et al.
NATURE COMMUNICATIONS (2018)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer
Shuzhen Liang et al.
ONCOTARGETS AND THERAPY (2017)
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer immunotherapy: Recent innovations and Future Developments
John P. Veluchamy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Restoring Natural Killer Cell immunity against Multiple Myeloma in the era of New Drugs
Gianfranco Pittari et al.
FRONTIERS IN IMMUNOLOGY (2017)
What Fuels Natural Killers? Metabolism and NK Cell Responses
Clair M. Gardiner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation
Xun Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
Sinead E. Keating et al.
JOURNAL OF IMMUNOLOGY (2016)
Nutrient Competition: A New Axis of Tumor Immunosuppression
Madhusudhanan Sukumar et al.
CELL (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Activation-Specific Metabolic Requirements for NK Cell IFN-γ Production
Molly P. Keppel et al.
JOURNAL OF IMMUNOLOGY (2015)
Effect of tumor cells and tumor microenvironment on NK-cell function
Massimo Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
Raymond P. Donnelly et al.
JOURNAL OF IMMUNOLOGY (2014)
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Antoine Marais et al.
NATURE IMMUNOLOGY (2014)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Metabolic Pathways in Immune Cell Activation and Quiescence
Erika L. Pearce et al.
IMMUNITY (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
Subhashis Sarkar et al.
PLOS ONE (2013)
The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity
Joanna Baginska et al.
FRONTIERS IN IMMUNOLOGY (2013)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Tumor Induced Inactivation of Natural Killer Cell Cytotoxic Function; Implication in Growth, Expansion and Differentiation of Cancer Stem Cells
Anahid Jewett et al.
JOURNAL OF CANCER (2011)
Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
Akiyoshi Hirayama et al.
CANCER RESEARCH (2009)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Dendritic cells mediate NK cell help for Th1 and CTL responses: Two-signal requirement for the induction of NK cell helper function
RB Mailliard et al.
JOURNAL OF IMMUNOLOGY (2003)
Cytokines and immune response in the tumor microenvironment
S Mocellin et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Share Paper
